{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:21:48Z","timestamp":1791181308583,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,2]],"date-time":"2012-01-02T00:00:00Z","timestamp":1325462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-9966-31-1","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T07:15:49Z","timestamp":1325574949000},"source":"Crossref","is-referenced-by-count":117,"title":["Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Qiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Z","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei G","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao H","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,2]]},"reference":[{"key":"553_CR1","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner SE: Cervical cancer. Lancet. 2003, 361: 2217-2225. 10.1016\/S0140-6736(03)13778-6.","journal-title":"Lancet"},{"issue":"suppl 3","key":"553_CR2","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","volume":"24","author":"AB Moscicki","year":"2006","unstructured":"Moscicki AB, Schiffman M, Kjaer S, Villa LL: Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine. 2006, 24 (suppl 3): S42-51.","journal-title":"Vaccine"},{"key":"553_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/plac.2001.0774","volume":"23","author":"K Udagawa","year":"2002","unstructured":"Udagawa K, Yasumitsu H, Esaki M, Sawada H, Nagashima Y, Aoki I, Jin M, Miyagi E, Nakazawa T, Hirahara F, Miyazaki K, Miyagi Y: Subcellularlocalization of PP5\/TFPI-2 in human placenta: a possible role of PP5\/TFPI-2 as an anti-coagulantonthe surface of syncytiotrophoblasts. Placenta. 2002, 23: 145-153. 10.1053\/plac.2001.0774.","journal-title":"Placenta"},{"key":"553_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1172\/JCI10403","volume":"107","author":"MP Herman","year":"2001","unstructured":"Herman MP, Sukhova GK, Kisiel W, Foster D, Kehry MR, Libby P, Sch\u00f6nbeck U: Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest. 2001, 107: 1117-1126. 10.1172\/JCI10403.","journal-title":"J Clin Invest"},{"key":"553_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0014-5793(02)02588-7","volume":"517","author":"T Sugiyama","year":"2002","unstructured":"Sugiyama T, Ishii S, Yamamoto J, Irie R, Saito K, Otuki T, Wakamatsu A, Suzuki Y, Hio Y, Ota T, Nishikawa T, Sugano S, Masuho Y, Isogai T: cDNA macroarray analysis of gene expression in synoviocytes stimulated with TNF alpha. FEBS Lett. 2002, 517: 121-128. 10.1016\/S0014-5793(02)02588-7.","journal-title":"FEBS Lett"},{"key":"553_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<749::AID-IJC21>3.0.CO;2-Y","volume":"76","author":"CN Rao","year":"1998","unstructured":"Rao CN, Cook B, LiuY Chilukuri K, Stack MS, Foster DC, Kisiel W, Woodley DT: HT-1080 fibrosarcoma cellmatrix degradationand invasion are inhibited by thematrix-associated serineprotease inhibitor TFPI-2\/33 kDaMSPI. Int JCancer. 1998, 76: 749-756. 10.1002\/(SICI)1097-0215(19980529)76:5<749::AID-IJC21>3.0.CO;2-Y.","journal-title":"Int JCancer"},{"key":"553_CR7","doi-asserted-by":"publisher","first-page":"17500","DOI":"10.1074\/jbc.M400802200","volume":"279","author":"HS Chand","year":"2004","unstructured":"Chand HS, Schmidt AE, Bajaj SP, Kisiel W: Structure function analysis of the reactive site in the first Kunitz type domain of human tissue factor pathway inhibitor-2. J Biol Chem. 2004, 279: 17500-17507. 10.1074\/jbc.M400802200.","journal-title":"J Biol Chem"},{"key":"553_CR8","first-page":"897","volume":"34","author":"M Libra","year":"2009","unstructured":"Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, Spandidos DA, Mazzarino C: Uterine cervical carcinoma: role of matrix metalloproteinases. International Journal of Oncology. 2009, 34: 897-904.","journal-title":"International Journal of Oncology"},{"key":"553_CR9","first-page":"1122","volume":"94","author":"Chand S Hitendra","year":"2005","unstructured":"Hitendra Chand, Donald Foster, Walter Kisiel: Structure, function andbiology of tissue factor pathway inhibitor-2. ThrombHaemost. 2005, 94: 1122-1130.","journal-title":"ThrombHaemost"},{"key":"553_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/1471-2407-10-617","volume":"10","author":"Wang Shumin","year":"2010","unstructured":"Shumin Wang, Xue Xiao, Xiaoying Zhou, Tingting Huang, Chunping Du, Nana Yu, Yingxi Mo, Longde Lin, Jinyan Zhang, Ning Ma, Mariko Murata, Guangwu Huang, Zhe Zhang: TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer. 2010, 10: 617-10.1186\/1471-2407-10-617.","journal-title":"BMC Cancer"},{"key":"553_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/hep.21578","volume":"45","author":"CM Wong","year":"2007","unstructured":"Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO: Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology. 2007, 45: 1129-1138. 10.1002\/hep.21578.","journal-title":"Hepatology"},{"key":"553_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/hum.2008.129","volume":"20","author":"Y Ran","year":"2009","unstructured":"Ran Y, Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z: A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma. Hum Gene Ther. 2009, 20: 41-49. 10.1089\/hum.2008.129.","journal-title":"Hum Gene Ther"},{"key":"553_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/1055-9965.EPI-05-0323","volume":"15","author":"P Sova","year":"2006","unstructured":"Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N: Discovery of Novel Methylation Biomarers in Cervical Carcinoma by Global Demethylation and Microarray Analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 114-123. 10.1158\/1055-9965.EPI-05-0323.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"553_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.virol.2004.09.045","volume":"331","author":"AD Santin","year":"2005","unstructured":"Santin AD, Zhan F, Bignotti E, Siegel ER, Can\u00e9 S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, Kay HH, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Pecorelli S: Gene expression profiles of primary HPV16-and HPV18-infected early stage cervical cancers and normal cervical epithetlium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology. 2005, 331: 269-291. 10.1016\/j.virol.2004.09.045.","journal-title":"Virology"},{"key":"553_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/01.ATV.18.1.40","volume":"18","author":"M Iino","year":"1998","unstructured":"Iino M, Foster DC, Kisiel W: Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arterioscler Thromb Vasc Biol. 1998, 18: 40-46. 10.1161\/01.ATV.18.1.40.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"553_CR16","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1515\/BC.2003.115","volume":"384","author":"F Hub\u00e9","year":"2003","unstructured":"Hub\u00e9 F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y: Transcriptional Silencing of the TFPI-2 Gene by Promoter Hypermethylation in Choriocarcinoma Cells. Biol Chem. 2003, 384: 1029-1034. 10.1515\/BC.2003.115.","journal-title":"Biol Chem"},{"key":"553_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2011.04.027","volume":"497","author":"F Gessler","year":"2011","unstructured":"Gessler F, Voss V, Seifert V, Gerlach R, K\u00f6gel D: Knockdown of TFPI-2 promotes migration and invasion of glioma cells. Neurosci Lett. 2011, 497: 49-54. 10.1016\/j.neulet.2011.04.027.","journal-title":"Neurosci Lett"},{"key":"553_CR18","first-page":"127","volume":"18","author":"SD Konduri","year":"2001","unstructured":"Konduri SD, Tasiou A, Chandrasekar N, Rao JS: Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. Int J Oncol. 2001, 18: 127-131.","journal-title":"Int J Oncol"},{"key":"553_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jss.2009.06.015","volume":"167","author":"Z Tang","year":"2011","unstructured":"Tang Z, Geng G, Huang Q, Xu G, Hu H, Chen J, Li J: Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo. J Surg Res. 2011, 167: 62-69. 10.1016\/j.jss.2009.06.015.","journal-title":"J Surg Res"},{"key":"553_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-009-9245-z","volume":"26","author":"S Iochmann","year":"2009","unstructured":"Iochmann S, Bl\u00e9chet C, Chabot V, Saulnier A, Amini A, Gaud G, Gruel Y, Reverdiau P: Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion. Clin Exp Metastasis. 2009, 26: 457-467. 10.1007\/s10585-009-9245-z.","journal-title":"Clin Exp Metastasis"},{"key":"553_CR21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0037-1613610","volume":"90","author":"MZ Wojtukiewicz","year":"2003","unstructured":"Wojtukiewicz MZ, Sierko E, Zimnoch L, Kozlowski L, Kisiel W: Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue. Thromb Haemost. 2003, 90: 140-146.","journal-title":"Thromb Haemost"},{"key":"553_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjc.6602298","volume":"92","author":"J Rollin","year":"2005","unstructured":"Rollin J, Iochmann S, Blechet C, Hube F, Regina S, Guyetant S, Lemarie E, Reverdiau P, Gruel Y: Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. British Journal of Cancer. 2005, 92: 775-783. 10.1038\/sj.bjc.6602298.","journal-title":"British Journal of Cancer"},{"key":"553_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2199-8-110","volume":"8","author":"Guo Hongshen","year":"2007","unstructured":"Hongshen Guo, Yifeng Lin, Hongwei Zhang, Juan Liu, Nong Zhang, Yiming Li, Desheng Kong, Qiqun Tang, Duan Ma: Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Molecular Biology. 2007, 8: 110-10.1186\/1471-2199-8-110.","journal-title":"BMC Molecular Biology"},{"key":"553_CR24","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/516784","volume":"195","author":"M Plummer","year":"2007","unstructured":"Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, ALTS Group: A 2-year prospective study of human papilloma virus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis. 2007, 195: 1582-1589. 10.1086\/516784.","journal-title":"J Infect Dis"},{"key":"553_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"PJ Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ: HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006, 208: 152-164. 10.1002\/path.1866.","journal-title":"J Pathol"},{"key":"553_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/jcp.49.2.134","volume":"49","author":"Y Shoji","year":"1996","unstructured":"Shoji Y, Saegusa M, Takano Y, Ohbu M, Okayasu I: Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol. 1996, 49: 134-138. 10.1136\/jcp.49.2.134.","journal-title":"J Clin Pathol"},{"key":"553_CR27","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1158\/1078-0432.CCR-06-3023","volume":"13","author":"George Joseph","year":"2007","unstructured":"Joseph George, Christopher Gondi, Dzung Dinh, Meena Gujrati, Jasti Rao: Restoration of TFPI-2 in a Human Glioblastoma Cell Line Triggers Caspase Mediated Pathway and Apoptosis. Clin Cancer Res. 2007, 13: 3507-3517. 10.1158\/1078-0432.CCR-06-3023.","journal-title":"Clin Cancer Res"},{"key":"553_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s10495-008-0207-8","volume":"13","author":"P Kempaiah","year":"2008","unstructured":"Kempaiah P, Kisiel W: Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line. Apoptosis. 2008, 13: 702-715. 10.1007\/s10495-008-0207-8.","journal-title":"Apoptosis"},{"key":"553_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0002-9440(10)64154-5","volume":"161","author":"SC Shih","year":"2002","unstructured":"Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE, Ali IU, Smith LE, Senger DR: Molecular profiling of angiogenesis markers. Am J Pathol. 2002, 161: 35-41. 10.1016\/S0002-9440(10)64154-5.","journal-title":"Am J Pathol"},{"key":"553_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2003-06-1930","volume":"103","author":"HS Chand","year":"2004","unstructured":"Chand HS, Du X, Ma D, Inzunza HD, Kamei S, Foster D, Brodie S, Kisiel W: The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. Blood. 2004, 103: 1069-1077.","journal-title":"Blood"},{"key":"553_CR31","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ijc.20965","volume":"115","author":"N Yanamandra","year":"2005","unstructured":"Yanamandra N, Kondraganti S, Gondi CS, Gujrati M, Olivero WC, Dinh DH, Rao JS: Recombinant adenoassocia- ted virus (rAAV) exp ressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. Int J Cancer. 2005, 115: 998-1005. 10.1002\/ijc.20965.","journal-title":"Int J Cancer"},{"key":"553_CR32","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1161\/01.ATV.0000248731.55781.87","volume":"26","author":"Xu Zhenhua","year":"2006","unstructured":"Zhenhua Xu, Debasish Maiti, Walter Kisiel, Elia Duh: Endothelial Cells Growth Factor and Suppresses Growth Factor-Induced Proliferation of Tissue Factor Pathway Inhibitor-2 Is Upregulated by Vascular Endothelial. Arterioscler Thromb Vasc Biol. 2006, 26: 2819-2825. 10.1161\/01.ATV.0000248731.55781.87.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-31-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-31-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-31-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:29:00Z","timestamp":1548232140000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-31-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-31-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,2]]},"article-number":"1"}}